Clinical Trial Update: A Clinical Trial of YMC017 in Hypertensive and Hypercholesterolemic Patients With Metabolic Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial of YMC017 in hypertensive and hypercholesterolemic patients with metabolic syndrome was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• YMC017

Snippet

Sponsor: Yuhan Corporation | Conditions: Metabolic Syndrome | Phase 4 | Status: TERMINATED